Dow Down 0.02% Nasdaq Up 0.07%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
3.10 Down 0.03(0.96%) Nov 25, 4:00PM EST
|After Hours : 3.10 Down 0.00 (0.01%) Nov 25, 4:35PM EST
Prev Close:3.13
Open:3.13
Bid:N/A
Ask:4.85 x 1000
1y Target Est:10.88
Beta:1.42
Next Earnings Date:N/A
Day's Range:3.03 - 3.16
52wk Range:2.62 - 7.22
Volume:1,045,455
Avg Vol (3m):1,273,310
Market Cap:335.93M
P/E (ttm):N/A
EPS (ttm):-0.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNTADown 0.96%335.93M
INFIUp 3.01%717.35M
NVSUp 0.28%229.87B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.89
Quarterly EPS Est (Dec-14) :-0.21
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback